All of these hypotheses merit further investigation – for example, via experimental evolution of malaria parasites[46] in host lineages particularly prone to immunopathological virulence such as the αIL-10R treated hosts in the present study, versus those particularly unlikely to exhibit immunopathology such as hosts to whom recombinant IL-10 is experimentally added. Here, IL10 is linked to malaria.